At a glance
ClinicalIndex Comparison RecordN/ACompleted· 64 enrolled
Drug / intervention
comfilcon A +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparing Biofinity Toric Multifocal to Ultra Multifocal for Astigmatism
In Brief
A clinical study evaluating comfilcon A and Samfilcon A for Astigmatism and Presbyopia. Completed, enrolled 64 participants across 7 sites in 2 countries.
Detailed Summary
The objective of the study was to compare the handling and performance of Biofinity Toric Multifocal to Ultra Multifocal for Astigmatism.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAstigmatism, Presbyopia
CountriesCanada, United States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedMay 2020
Enrollment StartAug 2020
Primary CompletionJul 2021
TodayJul 2026
First PostedMay 27, 2020
Enrollment StartAug 6, 2020
Primary CompletionJul 29, 2021
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 6.1 years ago
Interventions
comfilcon Adevice
Subjects will be randomized to wear comfilcon A for one month.
Samfilcon Adevice
Subjects will be randomized to wear samfilcon A for one month.